ACR appropriateness criteria® borderline and unresectable pancreas cancer

William Small, John P. Hayes, W. Warren Suh, Abdel Wahab May, Ross A. Abrams, Nilofer Azad, Prajnan Das, Jadranka Dragovic, Karyn A. Goodman, Salma K. Jabbour, William E. Jones, Andre A. Konski, Albert C. Koong, Rachit Kumar, Percy Lee, Timothy M. Pawlik, Joseph M. Herman

Research output: Contribution to journalReview article

Abstract

These guidelines review the use of radiation, chemotherapy, and surgery in borderline and unresectable pancreas cancer. Radiation technique, dose, and targets were evaluated, as was the recommended chemotherapy, administered either alone or concurrently with radiation. This report will aid clinicians in determining guidelines for the optimal treatment of borderline and unresectable pancreatic cancer.

Original languageEnglish (US)
JournalONCOLOGY (United States)
Volume30
Issue number7
StatePublished - Jul 15 2016

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'ACR appropriateness criteria® borderline and unresectable pancreas cancer'. Together they form a unique fingerprint.

  • Cite this

    Small, W., Hayes, J. P., Suh, W. W., May, A. W., Abrams, R. A., Azad, N., Das, P., Dragovic, J., Goodman, K. A., Jabbour, S. K., Jones, W. E., Konski, A. A., Koong, A. C., Kumar, R., Lee, P., Pawlik, T. M., & Herman, J. M. (2016). ACR appropriateness criteria® borderline and unresectable pancreas cancer. ONCOLOGY (United States), 30(7).